Roscigno RF - Search Results

1

Comparative bioavailability of inhaled treprostinil administered as LIQ861 and Tyvaso® in healthy subjects.

Roscigno RF, Vaughn T, Parsley E, Hunt T, Eldon MA, Rubin LJ. Roscigno RF, et al. Vascul Pharmacol. 2021 Jun;138:106840. doi: 10.1016/j.vph.2021.106840. Epub 2021 Feb 2. Vascul Pharmacol. 2021. PMID: 33545364 Clinical Trial.

2

Pharmacokinetics and tolerability of LIQ861, a novel dry-powder formulation of treprostinil.

Roscigno R, Vaughn T, Anderson S, Wargin W, Hunt T, Hill NS. Roscigno R, et al. Pulm Circ. 2020 Nov 19;10(4):2045894020971509. doi: 10.1177/2045894020971509. eCollection 2020 Oct-Dec. Pulm Circ. 2020. PMID: 33282202 Free PMC article.

3

Absolute bioavailability and pharmacokinetics of treprostinil sodium administered by acute subcutaneous infusion.

Wade M, Baker FJ, Roscigno R, DellaMaestra W, Hunt TL, Lai AA. Wade M, et al. J Clin Pharmacol. 2004 Jan;44(1):83-8. doi: 10.1177/0091270003261343. J Clin Pharmacol. 2004. PMID: 14681345 Clinical Trial.

4

Efficacy and safety of treprostinil: an epoprostenol analog for primary pulmonary hypertension.

McLaughlin VV, Gaine SP, Barst RJ, Oudiz RJ, Bourge RC, Frost A, Robbins IM, Tapson VF, McGoon MD, Badesch DB, Sigman J, Roscigno R, Blackburn SD, Arneson C, Rubin LJ, Rich S; Treprostinil Study Group. McLaughlin VV, et al. J Cardiovasc Pharmacol. 2003 Feb;41(2):293-9. doi: 10.1097/00005344-200302000-00019. J Cardiovasc Pharmacol. 2003. PMID: 12548091 Clinical Trial.

5

Pharmacokinetics of treprostinil sodium administered by 28-day chronic continuous subcutaneous infusion.

Wade M, Baker FJ, Roscigno R, DellaMaestra W, Arneson CP, Hunt TL, Lai AA. Wade M, et al. J Clin Pharmacol. 2004 May;44(5):503-9. doi: 10.1177/0091270004264638. J Clin Pharmacol. 2004. PMID: 15102871

6

TORREY, a Phase 2 study to evaluate the efficacy and safety of inhaled seralutinib for the treatment of pulmonary arterial hypertension.

Frantz RP, Benza RL, Channick RN, Chin K, Howard LS, McLaughlin VV, Sitbon O, Zamanian RT, Hemnes AR, Cravets M, Bruey JM, Roscigno R, Mottola D, Elman E, Zisman LS, Ghofrani HA. Frantz RP, et al. Pulm Circ. 2021 Nov 11;11(4):20458940211057071. doi: 10.1177/20458940211057071. eCollection 2021 Oct-Dec. Pulm Circ. 2021. PMID: 34790348 Free PMC article.

7

Generation of purified nitric oxide from liquid N2O4 for the treatment of pulmonary hypertension in hypoxemic swine.

Lovich MA, Fine DH, Denton RJ, Wakim MG, Wei AE, Maslov MY, Gamero LG, Vasquez GB, Johnson BJ, Roscigno RF, Gilbert RJ. Lovich MA, et al. Among authors: roscigno rf. Nitric Oxide. 2014 Feb 15;37:66-72. doi: 10.1016/j.niox.2014.02.001. Epub 2014 Feb 7. Nitric Oxide. 2014. PMID: 24513304

8

Inhaled Nitric Oxide Augments Left Ventricular Assist Device Capacity by Ameliorating Secondary Right Ventricular Failure.

Lovich MA, Pezone MJ, Wakim MG, Denton RJ, Maslov MY, Murray MR, Tsukada H, Agnihotri AK, Roscigno RF, Gamero LG, Gilbert RJ. Lovich MA, et al. Among authors: roscigno rf. ASAIO J. 2015 Jul-Aug;61(4):379-85. doi: 10.1097/MAT.0000000000000211. ASAIO J. 2015. PMID: 25710771

9

Nitrogen dioxide reducing ascorbic acid technologies in the ventilator circuit leads to uniform NO concentration during inspiration.

Pezone MJ, Wakim MG, Denton RJ, Gamero LG, Roscigno RF, Gilbert RJ, Lovich MA. Pezone MJ, et al. Among authors: roscigno rf. Nitric Oxide. 2016 Aug 31;58:42-50. doi: 10.1016/j.niox.2016.06.001. Epub 2016 Jun 2. Nitric Oxide. 2016. PMID: 27264784

10

Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial.

Frantz RP, McLaughlin VV, Sahay S, Escribano Subías P, Zolty RL, Benza RL, Channick RN, Chin KM, Hemnes AR, Howard LS, Sitbon O, Vachiéry JL, Zamanian RT, Cravets M, Roscigno RF, Mottola D, Osterhout R, Bruey JM, Elman E, Tompkins CA, Parsley E, Aranda R, Zisman LS, Ghofrani HA; TORREY Study Investigators. Frantz RP, et al. Among authors: roscigno rf. Lancet Respir Med. 2024 May 2:S2213-2600(24)00072-9. doi: 10.1016/S2213-2600(24)00072-9. Online ahead of print. Lancet Respir Med. 2024. PMID: 38705167

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page